Literature DB >> 7746261

Prevention and control of influenza recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.

.   

Abstract

These recommendations update information on the vaccine and antiviral agents available for controlling influenza during the 1995-96 influenza season (superseding MMWR 1994;43(No. RR-9) 1-13 and MMWR 1994;43(No. RR-15): 1-10). The principal changes include information about a) the influenza virus strains included in the trivalent vaccine for 1995-96, b) side effects and adverse reactions, and c) the vaccination of pregnant women.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7746261

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  17 in total

1.  Economic impact of providing workplace influenza vaccination. A model and case study application at a Brazilian pharma-chemical company.

Authors:  E Burckel; T Ashraf; J P de Sousa Filho; E Forleo Neto; H Guarino; C Yauti; B Barreto F de; L Champion
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

2.  Domain-constrained generation of clinical condition sets to help test computer-based clinical guidelines.

Authors:  P L Miller
Journal:  J Am Med Inform Assoc       Date:  2001 Mar-Apr       Impact factor: 4.497

3.  Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.

Authors:  J G Bartlett; S F Dowell; L A Mandell; T M File; D M Musher; M J Fine
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

4.  Health impact of influenza in the United States.

Authors:  K M Sullivan
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

5.  Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society.

Authors:  L A Mandell; T J Marrie; R F Grossman; A W Chow; R H Hyland
Journal:  Can J Infect Dis       Date:  2000-09

6.  Immunogenicity and safety of influenza vaccination in 3- to 6-year-old children with a two dose immunisation schedule.

Authors:  C Van Hoecke; W Raue; W Künzel; H Engelmann
Journal:  Eur J Pediatr       Date:  1996-04       Impact factor: 3.183

7.  Simultaneous influenza and pneumococcal vaccination in elderly individuals.

Authors:  G Grilli; L Fuiano; L R Biasio; F Pregliasco; A Plebani; M Leibovitz; A G Ugazio; F Vacca; M L Profeta
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

Review 8.  Antimicrobial resistance patterns in long term geriatric care. Implications for drug therapy.

Authors:  C A Mao; E L Siegler; E Abrutyn
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

9.  Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals.

Authors:  J J Goronzy; J W Fulbright; C S Crowson; G A Poland; W M O'Fallon; C M Weyand
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 10.  The clinical efficacy of influenza vaccination.

Authors:  A S Monto
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.